In a 9‑year‑old child with normal ferritin, normal serum iron, normal inflammatory markers and mildly elevated total iron‑binding capacity, does a transferrin saturation of 20% indicate early iron deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Transferrin Saturation of 20% in a 9-Year-Old Child

A transferrin saturation of 20% in this child with normal ferritin, normal serum iron, normal inflammatory markers, and mildly elevated TIBC represents the lower limit of normal and does NOT definitively indicate early iron deficiency. 1, 2, 3

Age-Specific Interpretation of Transferrin Saturation

  • Children aged 0.5-12 years have significantly lower transferrin saturation values than adults, with normal ranges extending well below the adult threshold of 20-50%. 1, 3

  • In healthy, iron-replete children (ferritin ≥15 μg/L), 19.9% had transferrin saturation values below 15%, and 8.2% had values below 10%, demonstrating that low TSAT is common in normal children. 2

  • The 2.5th percentile for transferrin saturation in iron-replete children is only 5%, meaning values as low as 5% can still be normal. 2

  • A transferrin saturation below 16% in children aged 0.5-12 years constitutes evidence of iron deficiency ONLY when accompanied by anemia and low mean corpuscular volume, not as an isolated finding. 3

Clinical Context of This Case

  • Normal ferritin excludes depleted iron stores, as ferritin is the most specific indicator of iron stores and would be low (<30 ng/mL) in true iron deficiency. 4, 1

  • Normal serum iron argues against iron-deficient erythropoiesis, as serum iron decreases when iron availability for red blood cell production is inadequate. 4, 1

  • Normal inflammatory markers exclude functional iron deficiency, which occurs when inflammation (elevated CRP/ESR) causes hepcidin to trap iron in storage sites despite adequate stores. 4, 1

  • The mildly elevated TIBC reflects increased transferrin synthesis, which can be a normal physiologic response during growth spurts in children rather than pathologic iron deficiency. 5, 6

Diagnostic Threshold Considerations

  • In adults without inflammation, TSAT <16% confirms iron deficiency, but this threshold does not apply to children due to developmental differences. 4, 1

  • In inflammatory conditions, TSAT <20% is used as the diagnostic threshold, but this child has normal inflammatory markers, making this criterion irrelevant. 1

  • For children specifically, transferrin saturation is unsuitable as a single diagnostic criterion and should always be combined with other indicators of iron status including ferritin, hemoglobin, and MCV. 2

Physiologic Changes During Growth

  • During pubertal development, serum transferrin increases and ferritin decreases as iron redistributes from stores to expanding red blood cell mass, which can lower TSAT without indicating true deficiency. 5, 6

  • The transferrin receptor-ferritin ratio is more sensitive than TSAT alone for detecting tissue iron deficiency in growing children, though it was not measured in this case. 6, 7

Clinical Recommendation

No intervention is warranted at this time. 2, 3 This child's TSAT of 20% sits at the lower limit of normal for age, but the constellation of normal ferritin, normal serum iron, and absence of anemia or microcytosis indicates adequate iron status. 1, 2, 3

Monitoring Strategy

  • Recheck complete blood count to confirm normal hemoglobin and MCV, as iron deficiency in children requires the triad of low TSAT, anemia, and low MCV. 3

  • If hemoglobin and MCV are normal, reassess iron parameters in 3-6 months to ensure stability during ongoing growth. 1

  • Consider measuring soluble transferrin receptor or sTfR/ferritin ratio if clinical suspicion for early iron deficiency persists despite normal standard parameters, as these are more sensitive in children. 4, 7

Common Pitfalls to Avoid

  • Do not apply adult TSAT thresholds to children, as this leads to overdiagnosis of iron deficiency and unnecessary iron supplementation. 2, 3

  • Do not interpret TSAT in isolation—always integrate ferritin, hemoglobin, MCV, and inflammatory markers to avoid misdiagnosis. 1, 2

  • Do not overlook normal physiologic changes during growth, when transferrin rises and ferritin falls as part of healthy iron redistribution to support expanding blood volume. 5, 6

Related Questions

In a child with a transferrin saturation of 20%, what is the appropriate management—iron supplementation or dietary monitoring with repeat iron studies?
Is a transferrin saturation of 20% in a 9‑year‑old child still consistent with iron deficiency given elevated total iron‑binding capacity and normal ferritin?
What is the recommended treatment for a child with a low transferring saturation index (TSI) without signs of anemia?
What dietary restrictions are recommended before serum ferritin and transferrin saturation level tests?
What is the difference between % transferrin saturation and serum transferrin?
In a 9-year-old child with elevated total iron‑binding capacity (~450 µg/dL) but normal ferritin, serum iron, and inflammatory markers, what is the appropriate next step in management?
In a child with a transferrin saturation of 20%, what is the appropriate management—iron supplementation or dietary monitoring with repeat iron studies?
Which medication other than metformin is recommended for improving insulin resistance?
In a cancer patient with neutrophilia and a high lymphocyte count (elevated neutrophil‑to‑lymphocyte ratio), what does this indicate and how should it be evaluated and managed?
In a cancer patient with neutropenia and lymphocytosis, what are the likely causes and how should it be managed?
What is the appropriate dosing schedule, baseline laboratory and ECG monitoring, contraindications, and dose‑adjustment guidelines for ribociclib in an adult with hormone‑receptor‑positive, HER2‑negative advanced breast cancer receiving endocrine therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.